• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

沙特阿拉伯吉达法赫德国王医院中东呼吸综合征冠状病毒感染的重症监护病房患者死亡率。

Mortality rate of ICU patients with the Middle East Respiratory Syndrome - Coronavirus infection at King Fahad Hospital, Jeddah, Saudi Arabia.

作者信息

Garout Mohammed A, Jokhdar Hani A A, Aljahdali Imad A, Zein Ahmed R, Goweda Reda A, Hassan-Hussein Abdurahman

机构信息

Department of Community Medicine, Faculty of Medicine, Umm Al-Qura University, Makkah, Kingdom of Saudi Arabia.

Intensive Care Department, King Fahad Hospital, Jeddah, Kingdom of Saudi Arabia.

出版信息

Cent Eur J Public Health. 2018 Jun;26(2):87-91. doi: 10.21101/cejph.a4764.

DOI:10.21101/cejph.a4764
PMID:30102495
Abstract

OBJECTIVE

The Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is a novel coronavirus circulating in the Arabian Peninsula since September 2012. It leads to significant respiratory disease and among patients with co-morbidities is associated with high mortality. This research studied the mortality rate of MERS-CoV among intensive care unit (ICU) patients and the correlation of mortality with different co-morbidities.

METHODS

This was a retrospective observational study conducted at the Intensive Care Unit of the King Fahad Hospital, Jeddah, Saudi Arabia. Data was obtained through patient chart review.

RESULTS

The total sample consisted of 52 laboratory-confirmed MERS-CoV infection patients. 39 patients died, with a 75% case-fatality rate. Many patients had underlying co-morbidities, including diabetes mellitus (51.9%), hypertension (46.2%), and chronic renal disease (21.2%).

CONCLUSIONS

MERS-CoV ICU mortality remains markedly high due to a combination of factors; the disease process of MERS-CoV leads to multiple organ failure, particularly respiratory and renal failure.

摘要

目的

中东呼吸综合征冠状病毒(MERS-CoV)是一种自2012年9月起在阿拉伯半岛传播的新型冠状病毒。它会引发严重的呼吸系统疾病,在患有合并症的患者中死亡率很高。本研究调查了重症监护病房(ICU)中MERS-CoV患者的死亡率以及死亡率与不同合并症之间的相关性。

方法

这是一项在沙特阿拉伯吉达法赫德国王医院重症监护病房进行的回顾性观察研究。数据通过查阅患者病历获得。

结果

总样本包括52例实验室确诊的MERS-CoV感染患者。39例患者死亡,病死率为75%。许多患者有潜在的合并症,包括糖尿病(51.9%)、高血压(46.2%)和慢性肾病(21.2%)。

结论

由于多种因素的综合作用,MERS-CoV在ICU中的死亡率仍然显著较高;MERS-CoV的疾病进程会导致多器官功能衰竭,尤其是呼吸和肾衰竭。

相似文献

1
Mortality rate of ICU patients with the Middle East Respiratory Syndrome - Coronavirus infection at King Fahad Hospital, Jeddah, Saudi Arabia.沙特阿拉伯吉达法赫德国王医院中东呼吸综合征冠状病毒感染的重症监护病房患者死亡率。
Cent Eur J Public Health. 2018 Jun;26(2):87-91. doi: 10.21101/cejph.a4764.
2
Characteristics and Outcomes of Middle East Respiratory Syndrome Coronavirus Patients Admitted to an Intensive Care Unit in Jeddah, Saudi Arabia.沙特阿拉伯吉达市一家重症监护病房收治的中东呼吸综合征冠状病毒患者的特征与转归
J Intensive Care Med. 2016 Jun;31(5):344-8. doi: 10.1177/0885066615579858. Epub 2015 Apr 9.
3
Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia.沙特阿拉伯王国一家冠状病毒转诊中心中东呼吸综合征冠状病毒(MERS-CoV)感染患者的治疗结果。
BMC Infect Dis. 2016 Apr 21;16:174. doi: 10.1186/s12879-016-1492-4.
4
Surveillance and Testing for Middle East Respiratory Syndrome Coronavirus, Saudi Arabia, April 2015-February 2016.沙特阿拉伯2015年4月至2016年2月中东呼吸综合征冠状病毒的监测与检测
Emerg Infect Dis. 2017 Apr;23(4):682-685. doi: 10.3201/eid2304.161793.
5
Early identification of pneumonia patients at increased risk of Middle East respiratory syndrome coronavirus infection in Saudi Arabia.早期识别在沙特阿拉伯感染中东呼吸综合征冠状病毒感染风险增加的肺炎患者。
Int J Infect Dis. 2018 May;70:51-56. doi: 10.1016/j.ijid.2018.03.005. Epub 2018 Mar 14.
6
Macrolides in critically ill patients with Middle East Respiratory Syndrome.重症中东呼吸综合征患者的大环内酯类药物。
Int J Infect Dis. 2019 Apr;81:184-190. doi: 10.1016/j.ijid.2019.01.041. Epub 2019 Jan 25.
7
2014 MERS-CoV outbreak in Jeddah--a link to health care facilities.2014年吉达的中东呼吸综合征冠状病毒疫情——与医疗保健机构的关联
N Engl J Med. 2015 Feb 26;372(9):846-54. doi: 10.1056/NEJMoa1408636.
8
Occurrence of the Middle East Respiratory Syndrome Coronavirus (MERS-CoV) across the Gulf Corporation Council countries: Four years update.中东呼吸综合征冠状病毒(MERS-CoV)在海湾阿拉伯国家合作委员会各国的出现:四年期更新情况
PLoS One. 2017 Oct 13;12(10):e0183850. doi: 10.1371/journal.pone.0183850. eCollection 2017.
9
Spatiotemporal Clustering of Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Incidence in Saudi Arabia, 2012-2019.2012-2019 年沙特阿拉伯中东呼吸综合征冠状病毒(MERS-CoV)发病率的时空聚集性。
Int J Environ Res Public Health. 2019 Jul 15;16(14):2520. doi: 10.3390/ijerph16142520.
10
Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics.中东呼吸综合征冠状病毒(MERS-CoV)感染:流行病学、发病机制和临床特征。
Eur Rev Med Pharmacol Sci. 2018 Aug;22(15):4956-4961. doi: 10.26355/eurrev_201808_15635.

引用本文的文献

1
Antimicrobial use and mortality among intensive care unit patients with bloodstream infections: implications for stewardship programs.重症监护病房血流感染患者的抗菌药物使用与死亡率:对管理计划的启示
Heliyon. 2022 Aug 4;8(8):e10076. doi: 10.1016/j.heliyon.2022.e10076. eCollection 2022 Aug.
2
Increased complications of COVID-19 in people with cardiovascular disease: Role of the renin-angiotensin-aldosterone system (RAAS) dysregulation.心血管疾病患者 COVID-19 并发症增加:肾素-血管紧张素-醛固酮系统(RAAS)失调的作用。
Chem Biol Interact. 2022 Jan 5;351:109738. doi: 10.1016/j.cbi.2021.109738. Epub 2021 Nov 3.
3
Interferon therapy in patients with SARS, MERS, and COVID-19: A systematic review and meta-analysis of clinical studies.
干扰素治疗 SARS、MERS 和 COVID-19 患者:临床研究的系统评价和荟萃分析。
Eur J Pharmacol. 2021 Sep 5;906:174248. doi: 10.1016/j.ejphar.2021.174248. Epub 2021 Jun 12.
4
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and Middle East Respiratory Syndrome Coronavirus (MERS-CoV) coinfection: A unique case series.严重急性呼吸综合征冠状病毒 2 型(SARS-CoV-2)与中东呼吸综合征冠状病毒(MERS-CoV)合并感染:一个独特的病例系列。
Travel Med Infect Dis. 2021 May-Jun;41:102026. doi: 10.1016/j.tmaid.2021.102026. Epub 2021 Mar 13.
5
Treatment of severe acute respiratory syndrome (SARS), Middle East respiratory syndrome (MERS), and coronavirus disease 2019 (COVID-19): a systematic review of , , and clinical trials.严重急性呼吸综合征(SARS)、中东呼吸综合征(MERS)和 2019 冠状病毒病(COVID-19)的治疗:系统评价、综述和临床试验。
Theranostics. 2021 Jan 1;11(3):1207-1231. doi: 10.7150/thno.48342. eCollection 2021.
6
Coronavirus-associated kidney outcomes in COVID-19, SARS, and MERS: a meta-analysis and systematic review.新型冠状病毒肺炎、严重急性呼吸综合征和中东呼吸综合征相关的肾脏结局:荟萃分析和系统评价。
Ren Fail. 2020 Nov 9;43(1):1-15. doi: 10.1080/0886022X.2020.1847724.
7
Prevalence of Diabetes Mellitus and Its Associated Unfavorable Outcomes in Patients With Acute Respiratory Syndromes Due to Coronaviruses Infection: A Systematic Review and Meta-Analysis.冠状病毒感染所致急性呼吸综合征患者中糖尿病的患病率及其相关不良结局:一项系统评价和荟萃分析。
Clin Med Insights Endocrinol Diabetes. 2020 Oct 19;13:1179551420962495. doi: 10.1177/1179551420962495. eCollection 2020.
8
A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.新型冠状病毒表现的全面综述——在致命的 COVID-19 全球大流行背景下。
Am J Med Sci. 2020 Jul;360(1):5-34. doi: 10.1016/j.amjms.2020.05.006. Epub 2020 May 11.
9
Comparison of clinical characteristics and outcomes of patients with coronavirus disease 2019 at different ages.2019年冠状病毒病不同年龄段患者的临床特征及预后比较。
Aging (Albany NY). 2020 Jun 4;12(11):10070-10086. doi: 10.18632/aging.103298.
10
Advances in the relationship between coronavirus infection and cardiovascular diseases.冠状病毒感染与心血管疾病关系的研究进展。
Biomed Pharmacother. 2020 Jul;127:110230. doi: 10.1016/j.biopha.2020.110230. Epub 2020 May 13.